In this fundamental analysis report, analysts William Wastenson and Neo Fuchs take a closer look at ChemoMetec, a Danish medtech company supplying cell counting instruments to pharmaceutical
and biotech companies. The share price has declined approximately 50% following a temporary US government shutdown and two subsequent guidance reductions, yet the recurring revenue base continued growing throughout.
In this fundamental analysis, analysts Dennis Drevell Smith and Anna-Brita Hunter Nilsson examine Paxman AB, a UK based MedTech company operating a de facto monopoly in mechanical scalp cooling. An equally weighted DCF and relative valuation imply a potential upside of 58%, making Paxman a compelling buy opportunity.
In this fundamental analysis report, analysts Måns Rössberger and Emma Rosberg take a closer look at Careium AB, a Swedish provider of telecare solutions for seniors. Despite market concerns related to management changes and prior deficiencies in financial communication, Careium is positioned to benefit from a structurally growing market driven by aging demographics, with revenue projected to grow at a 4.0% CAGR through 2027.
In this equity research report, analysts Anton Andersson and Nils Annborn takes a closer look at Carasent, a Nordic provider of modern EHR systems, enabling doctors to spend less time on administrative tasks and more time with patients.
